The last week has been packed with news across the startup world. It seems like everywhere you turn, another company is landing fresh funding, teaming up with ...

Mayo Clinic also notes that colon cancer symptoms can also present themselves with more frequent diarrhoea or constipation, ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...

The Business Research Company's Asthma and COPD Drugs Market 2025: Strategic Insights for Growth, Expansion, and Gaining Competitive Edge It will grow to $50.99 billion in 2029 at a compound annual ...

It will grow to $2.12 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, July 4, 2025 /EINPresswire.com/ -- Save ...

While Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...

Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

Eli Lilly is grabbing investor attention thanks to sharp earnings and revenue growth projections, though its Zacks Rank ...

Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...